Citation: Yuxun Lu, Jiajia Xu, Zongyun Jia, Siyu Kong, Yimu Qiao, Lin Li, Qiong Wu, Ying Zhou. A near-infrared multifunctional fluorescent probe for hypoxia monitoring and tumor-targeted therapy[J]. Chinese Chemical Letters, ;2022, 33(3): 1589-1594. doi: 10.1016/j.cclet.2021.09.013 shu

A near-infrared multifunctional fluorescent probe for hypoxia monitoring and tumor-targeted therapy

Yuxun Lu ^{a, 1} ,
Jiajia Xu ^{b, 1} ,
Zongyun Jia ^a ,
Siyu Kong ^a ,
Yimu Qiao ^a ,
Lin Li ^b ,
Qiong Wu ^{b, *,} ,
Ying Zhou ^{a, 1,}

a.
College of Chemical Science and Technology, Yunnan University, Kunming 650091, China
b.
Key Laboratory of Flexible Electronics (KLOFE) & Institute of Advanced Materials (IAM), Jiangsu National Synergetic Innovation Center for Advanced Materials (SICAM), Nanjing Tech University (NanjingTech), Nanjing 211816, China

iamqwu@njtech.edu.cn

yingzhou@ynu.edu.cn

Received Date: 5 July 2021
Revised Date: 1 September 2021
Accepted Date: 1 September 2021
Available Online: 8 September 2021

Figures(6)

Hypoxia is one of the key characteristics of solid tumors. The over-expression of azoreductase resulting from hypoxia can be used as a target to visualize hypoxic levels and a trigger of the drug release system in tumor treatment. In this work, we developed a near-infrared fluorescent probe YLOD, composed of a near-infrared fluorophore, an azo bond, and an analogue of the anti-tumor drug melphalan. In the presence of azoreductase, YLOD displayed a red emission at 620 nm and released the anti-tumor drug concomitantly, thus achieving the integrated effects of hypoxic imaging and tumor treatment. Furthermore, YLOD successfully inhibited the growth of solid tumors during the tumor suppression experiments in nude mice. Considering all the results, YLOD emerges as a new fluorescence tool that can quickly determine the location and the edges of a tumor, showing concrete potential in clinical cancer treatment.
- Azoreductase,
- Hypoxia,
- Theranostic,
- Tumor
1. [1]
  R.L. Siegel, K.D. Miller, A. Jemal, CA Cancer J. Clin. 69 (2019) 7-34. doi: 10.3322/caac.21551
2. [2]
  R.L. Siegel, K.D. Miller, H.E. Fuchs, et al., CA Cancer J. Clin. 71 (2021) 7-33. doi: 10.3322/caac.21654
3. [3]
  L. Wu, Y. Sun, K. Sugimoto, et al., J. Am. Chem. Soc. 140 (2018) 16340-16352. doi: 10.1021/jacs.8b10176
4. [4]
  D. Yue, M. Wang, F. Deng, et al., Chin. Chem. Lett. 29 (2018) 648-656. doi: 10.1016/j.cclet.2018.01.046
5. [5]
  J. Li, Z. Su, C. Yu, et al., Dyes Pigm. 192 (2021) 109451. doi: 10.1016/j.dyepig.2021.109451
6. [6]
  T. Cao, L. Zhang, H. Ma, et al., Sens. Actuators B: Chem. 338 (2021) 129841. doi: 10.1016/j.snb.2021.129841
7. [7]
  Z. Chai, D. Liu, X. Li, et al., Chem. Commun. 57 (2021) 5063-5066. doi: 10.1039/d1cc01462e
8. [8]
  Y. Zhao, S. Wu, J. Wu, et al., Cancer Biol. Ther. 11 (2011) 95-107. doi: 10.4161/cbt.11.1.13960
9. [9]
  L.B. Harrison, M. Chadha, R.J. Hill, et al., Oncologist 7 (2002) 492-508. doi: 10.1634/theoncologist.7-6-492
10. [10]
  J. Cummings, V.J. Spanswick, M. Tomasz, et al., Biochem. Pharmacol. 56 (1998) 405-414. doi: 10.1016/S0006-2952(98)00073-2
11. [11]
  P. Vaupel, L. Harrison, Oncologist 9 (2004) 4-9. doi: 10.1634/theoncologist.9-90005-4
12. [12]
  S. Kizaka-Kondoh, H. Konse-Nagasawa, Cancer Sci. 100 (2009) 1366-1373. doi: 10.1111/j.1349-7006.2009.01195.x
13. [13]
  Y. Zhou, K.N. Bobba, X.W. Lv, et al, Analyst 142 (2017) 345-350. doi: 10.1039/C6AN02107G
14. [14]
  D. Yang, H.Y. Tian, T.N. Zang, et al., Sci. Rep. 7 (2017) 9174. doi: 10.1038/s41598-017-09525-2
15. [15]
  X. Li, J. Wang, R. Cui, et al., Dyes Pigm. 179 (2020) 108395. doi: 10.1016/j.dyepig.2020.108395
16. [16]
  M. Gao, F. Yu, C. Lv, et al., Chem. Soc. Rev. 46 (2017) 2237-2271. doi: 10.1039/C6CS00908E
17. [17]
  C. Yan, L. Shi, Z. Guo, et al., Chin. Chem. Lett. 30 (2019) 1849-1855. doi: 10.1016/j.cclet.2019.08.038
18. [18]
  R. Kumari, D. Sunil, R.S. Ningthoujam, et al., Chem. Biol. Interact. 307 (2019) 91-104. doi: 10.1016/j.cbi.2019.04.034
19. [19]
  J. Jantsch, D. Chakravortty, N. Turza, et al., J. Immunol. 180 (2008) 4697-4705. doi: 10.4049/jimmunol.180.7.4697
20. [20]
  X. Tian, Z. Li, Y. Sun, et al., Anal. Chem. 90 (2018) 13759-13766. doi: 10.1021/acs.analchem.8b04249
21. [21]
  Y. Zhou, M. Maiti, A. Sharma, et al., J. Control. Release 288 (2018) 14-22. doi: 10.12792/jmti.5.2.14
22. [22]
  C. Yan, Y. Zhang, Z. Guo, Coordin. Chem. Rev. 427 (2021) 213556. doi: 10.1016/j.ccr.2020.213556
23. [23]
  X. Jiang, L. Rong, J. Cao, et al., Dyes Pigm. 191 (2021) 109375. doi: 10.1016/j.dyepig.2021.109375
24. [24]
  L. Yu, P. Verwilst, I. Shim, et al., CCS Chem. 2 (2020) 2725-2739.
25. [25]
  Q. Cai, T. Yu, W. Zhu, et al., Chem. Commun. 51 (2015) 14739-14741. doi: 10.1039/C5CC05518K
26. [26]
  O. Tangen, J. Jonsson, S. Orrenius, Anal. Biochem. 54 (1973) 597-603. doi: 10.1016/0003-2697(73)90392-8
27. [27]
  C. J. Hu, L. Y. Wang, L.A. Chodosh, et al., Mol. Cell. Biol. 23 (2003) 9361-9374. doi: 10.1128/MCB.23.24.9361-9374.2003
28. [28]
  Y.H. Pan, X.X. Chen, L. Dong, et al., Chin. Chem. Lett. 32 (2021) 3895–3898. doi: 10.1016/j.cclet.2021.06.024
29. [29]
  R. Wisdom, R.S. Johnson, C. Moore, EMBO. J. 18 (1999) 188-197. doi: 10.1093/emboj/18.1.188
30. [30]
  W.C. Yeh, J.L. de la Pompa, M.E. McCurrach, Science 279 (1998) 1954-1958. doi: 10.1126/science.279.5358.1954
31. [31]
  F. Gao, P. Okunieff, Z. Han, et al., Adv. Exp. Med. Biol. 566 (2005) 249-256. doi: 10.1007/0-387-26206-7_33
1. [1]
  Zihong Li , Jie Cheng , Ping Huang , Guoliang Wu , Weiying Lin . Activatable photoacoustic bioprobe for visual detection of aging in vivo. Chinese Chemical Letters, 2024, 35(4): 109153-. doi: 10.1016/j.cclet.2023.109153
2. [2]
  Cheng-Zhe Gao , Hao-Ran Jia , Tian-Yu Wang , Xiao-Yu Zhu , Xiaofeng Han , Fu-Gen Wu . A dual drug-loaded tumor vasculature-targeting liposome for tumor vasculature disruption and hypoxia-enhanced chemotherapy. Chinese Chemical Letters, 2025, 36(1): 109840-. doi: 10.1016/j.cclet.2024.109840
3. [3]
  Jin Wang , Xiaoyan Pan , Junyu Zhang , Qingqing Zhang , Yanchen Li , Weiwei Guo , Jie Zhang . Active molecule-based theranostic agents for tumor vasculature normalization and antitumor efficacy. Chinese Chemical Letters, 2024, 35(8): 109187-. doi: 10.1016/j.cclet.2023.109187
4. [4]
  Jia-Qi Feng , Xiang Tian , Rui-Ge Cao , Yong-Xiu Li , Wen-Long Liu , Rong Huang , Si-Yong Qin , Ai-Qing Zhang , Yin-Jia Cheng . An AIE-based theranostic nanoplatform for enhanced colorectal cancer therapy: Real-time tumor-tracking and chemical-enhanced photodynamic therapy. Chinese Chemical Letters, 2024, 35(12): 109657-. doi: 10.1016/j.cclet.2024.109657
5. [5]
  Chao Zhang , Ai-Feng Liu , Shihui Li , Fang-Yuan Chen , Jun-Tao Zhang , Fang-Xing Zeng , Hui-Chuan Feng , Ping Wang , Wen-Chao Geng , Chuan-Rui Ma , Dong-Sheng Guo . A supramolecular formulation of icariin@sulfonatoazocalixarene for hypoxia-targeted osteoarthritis therapy. Chinese Chemical Letters, 2025, 36(1): 109752-. doi: 10.1016/j.cclet.2024.109752
6. [6]
  Ling-Ling Wu , Xiangchuan Meng , Qingyang Zhang , Xiaowan Han , Feiya Yang , Qinghua Wang , Hai-Yu Hu , Nianzeng Xing . Heavy-atom engineered hypoxia-responsive probes for precisive photoacoustic imaging and cancer therapy. Chinese Chemical Letters, 2024, 35(4): 108663-. doi: 10.1016/j.cclet.2023.108663
7. [7]
  Liangliang Jia , Ye Hong , Xinyu He , Ying Zhou , Liujiao Ren , Hongjun Du , Bin Zhao , Bin Qin , Zhe Yang , Di Gao . Fighting hypoxia to improve photodynamic therapy-driven immunotherapy: Alleviating, exploiting and disregarding. Chinese Chemical Letters, 2025, 36(2): 109957-. doi: 10.1016/j.cclet.2024.109957
8. [8]
  Fengyun Li , Zerong Pei , Shuting Chen , Gen li , Mengyang Liu , Liqin Ding , Jingbo Liu , Feng Qiu . Multifunctional nano-herb based on tumor microenvironment for enhanced tumor therapy of gambogic acid. Chinese Chemical Letters, 2024, 35(5): 108752-. doi: 10.1016/j.cclet.2023.108752
9. [9]
  Xiaohong Wen , Mei Yang , Lie Li , Mingmin Huang , Wei Cui , Suping Li , Haiyan Chen , Chen Li , Qiuping Guo . Enzymatically controlled DNA tetrahedron nanoprobes for specific imaging of ATP in tumor. Chinese Chemical Letters, 2024, 35(8): 109291-. doi: 10.1016/j.cclet.2023.109291
10. [10]
  Tao LIU , Yuting TIAN , Ke GAO , Xuwei HAN , Ru'nan MIN , Wenjing ZHAO , Xueyi SUN , Caixia YIN . A photothermal agent with high photothermal conversion efficiency and high stability for tumor therapy. Chinese Journal of Inorganic Chemistry, 2024, 40(8): 1622-1632. doi: 10.11862/CJIC.20240107
11. [11]
  Jiangshan Xu , Weifei Zhang , Zhengwen Cai , Yong Li , Long Bai , Shaojingya Gao , Qiang Sun , Yunfeng Lin . Tetrahedron DNA nanostructure/iron-based nanomaterials for combined tumor therapy. Chinese Chemical Letters, 2024, 35(11): 109620-. doi: 10.1016/j.cclet.2024.109620
12. [12]
  Zhihui Zhang , Ru Sun , Chong Bian , Hongbo Wang , Zhen Zhao , Panpan Lv , Jianzhong Lu , Haixin Zhang , Hulie Zeng , Yuanyuan Chen , Zhijuan Cao . A dual-protease-triggered chemiluminescent probe for precise tumor imaging. Chinese Chemical Letters, 2025, 36(2): 109784-. doi: 10.1016/j.cclet.2024.109784
13. [13]
  Yi Cao , Xiaojiao Ge , Yuanyuan Wei , Lulu He , Aiguo Wu , Juan Li . Tumor microenvironment-activatable neuropeptide-drug conjugates enhanced tumor penetration and inhibition via multiple delivery pathways and calcium deposition. Chinese Chemical Letters, 2024, 35(4): 108672-. doi: 10.1016/j.cclet.2023.108672
14. [14]
  Ting Pan , Dinghu Zhang , Guomei You , Xiaoxia Wu , Chenguang Zhang , Xinyu Miao , Wenzhi Ren , Yiwei He , Lulu He , Yuanchuan Gong , Jie Lin , Aiguo Wu , Guoliang Shao . PD-L1 targeted iron oxide SERS bioprobe for accurately detecting circulating tumor cells and delineating tumor boundary. Chinese Chemical Letters, 2025, 36(1): 109857-. doi: 10.1016/j.cclet.2024.109857
15. [15]
  Botao QU , Qian WANG , Xiaogang NING , Yuxin ZHOU , Ruiping ZHANG . Deeply penetrating photoacoustic imaging in tumor tissues based on dual-targeted melanin nanoparticle. Chinese Journal of Inorganic Chemistry, 2024, 40(5): 1025-1032. doi: 10.11862/CJIC.20230416
16. [16]
  Wen Xiao , Fazhan Wang , Yangzhuo Gu , Xi He , Na Fan , Qian Zheng , Shugang Qin , Zhongshan He , Yuquan Wei , Xiangrong Song . PEG400-mediated nanocarriers improve the delivery and therapeutic efficiency of mRNA tumor vaccines. Chinese Chemical Letters, 2024, 35(5): 108755-. doi: 10.1016/j.cclet.2023.108755
17. [17]
  Yihao Zhang , Yang Jiao , Xianchao Jia , Qiaojia Guo , Chunying Duan . Highly effective self-assembled porphyrin MOCs nanomaterials for enhanced photodynamic therapy in tumor. Chinese Chemical Letters, 2024, 35(5): 108748-. doi: 10.1016/j.cclet.2023.108748
18. [18]
  Zhe Li , Ping-Zhao Liang , Li Xu , Fei-Yu Yang , Tian-Bing Ren , Lin Yuan , Xia Yin , Xiao-Bing Zhang . Three positive charge nonapoptotic-induced photosensitizer with excellent water solubility for tumor therapy. Chinese Chemical Letters, 2024, 35(8): 109190-. doi: 10.1016/j.cclet.2023.109190
19. [19]
  Feng Wu , Xuemin Kong , Yixuan Liu , Shuli Wang , Zhong Chen , Xu Hou . Microfluidic-based isolation of circulating tumor cells with high-efficiency and high-purity. Chinese Chemical Letters, 2024, 35(8): 109754-. doi: 10.1016/j.cclet.2024.109754
20. [20]
  An Lu , Yuhao Guo , Yi Yan , Lin Zhai , Xiangyu Wang , Weiran Cao , Zijie Li , Zhixia Zhao , Yujie Shi , Yuanjun Zhu , Xiaoyan Liu , Huining He , Zhiyu Wang , Jian-Cheng Wang . Nanomedicine integrating the lipidic derivative of 5-fluorouracil, miriplatin and PD-L1 siRNA for enhancing tumor therapy. Chinese Chemical Letters, 2024, 35(6): 108928-. doi: 10.1016/j.cclet.2023.108928

Get Citation

PDF

XML

Metrics

PDF Downloads(8)
Abstract views(718)
HTML views(148)

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142